A transdermal microemulsion-based hydrogel of nisoldipine: Preparation, in vitro characterization and in vivo pharmacokinetic evaluation

Yan Xiao,Zhiyi Lin,Jianping Liu,Wenli Zhang,Ling Wang,Panpan Yu

IF: 9.273

2012-01-01

Asian Journal of Pharmaceutical Sciences

Abstract:The purpose of this study was to construct a microemulsion-based hydrogel (MEs-H) for the transdermal delivery of an anti-hypertensive drug nisoldipine (NS) and to evaluate, predict its in vivo pharmacokinetic behaviors in rats using convolution method. Compositions of the nisoldipine microemulsions (NS-MEs) were determined by simplex lattice mixture design. The nisoldipine microemulsion-based hydrogel (NS-MEs-H) was prepared by adding carbomer. The NS-MEs and NS-MEs-H were characterized by size, morphology and in vitro skin permeation behaviors. In vivo drug plasma concentrations in rats were determined by LC/MS. The drug bioavailability of NS-MEs-H was compared with that of oral suspension. Pharmacokinetic behaviors of NS-MEs-H were predicted by convolution method. The optimized NS-MEs were composed of isopropyl myristate (IPM, 3%, w/w), Cremophor EL (15%, w/w), Transcutol® (22%, w/w) and water (60%, w/w). The Size of the NS-MEs was 23.1±2.4 nm and the spherical droplets existed in both NS-MEs and NS-MEs-H. The cumulative amount of NS permeated from NS-MEs and NS-MEs-H were 599.91±49.83 and 461.47±38.33 μg/cm2 during 72 hours(h) repectively. The pharmacokinetic results showed that transdermal administration of NS-MEs-H could maintain a steady drug plasma concentration in three days. The NS bioavailability of NS-MEs-H was 1.55-fold increased than that of the oral administration. Percent prediction errors of most drug plasma concentrations were below 10%. The NS-MEs-H has the potential to provide a long effective treatment of hypertension, and the convolution method could be utilized to predict in vivo pharmacokinetic behaviors of transdermal drug delivery systems in the preliminary study.